Medical technology firm GE Healthcare and augmented reality (AR) med-tech company MediView XR have forged a partnership to develop the OmnifyXR Interventional Suite System for AR-based medical imaging for the interventional space.
The partnership is intended to advance precision care using intuitive visualisation, remote collaboration, and insights based on evidence.
MediView’s existing technology combines spatial computing and mixed reality with medical imaging.
GE Healthcare said that the OmnifyXR solution offers a heads-up, AR display of interventional x-ray imaging equipment by using Microsoft’s HoloLens technology. The system is said to have numerous holographic displays of live imaging to help with ergonomics.
It also has a 3D volume for increased anatomy visualisation to help physicians examine complex anatomies and make informed clinical decisions. The system includes remote collaboration, which allows doctors to collaborate remotely, train, supervise, and promote collaborative care, the medical technology firm claimed.
GE Healthcare global interventional general manager Arnaud Marie said: “Augmented reality in imaging is key to improved visualisation of anatomy and enhanced user experience.
“Our collaboration with MediView demonstrates our commitment to advancing the delivery of precision care by expanding the capabilities of our own imaging guided systems through an open architecture and the integration of promising and complementary technologies, like OmnifyXR Interventional Suite, into clinical workflow.
“Together, we can help clinicians use image guidance technologies to their full potential in order to help in the delivery of high-quality patient care.”
In a separate development, the medical technology firm signed an agreement with ulrich medical for a branded contrast media injector in the US.
Under the partnership, GE Healthcare will offer its own brand computed tomography (CT) motion injector, which is a multi-dose, syringeless technology designed and manufactured by ulrich medical, to the injector market in the US.
